Logopeediline teraapia OÜ
Logopeediline teraapia OÜ is a OÜ based in Tartu linn, registry code 12546158, status: active. Main activity: Other human health activities n.e.c.. Its annual report for 2025 shows revenue of €17 268 and 0 employees.
Q3 2025 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Revenue · 2025 17 268 €above 47% of companiesindustry median 20 811 € · companies in the industry: 3 373
- Net profit margin · 2025 -26.7 %above 8% of companiesindustry median 8.3 % · companies in the industry: 2 759
Taxes and turnover
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2025 | — | 71 | 71 | — |
| Q2 2025 | — | 71 | 71 | — |
| Q4 2024 | — | 199 | 199 | — |
| Q3 2024 | — | 133 | 133 | — |
| Q2 2024 | — | 2 791 | 379 | — |
| Q1 2024 | — | 350 | 370 | — |
Financials by year
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | 17 268 | -4 619 | 341 | 3 136 | 3 136 | 0 |
| 2024 | 13 451 | 138 | 2 472 | 7 757 | 7 757 | 0 |
| 2023 | 14 819 | 10 216 | 347 | 12 860 | 10 216 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2018 | — | — | — | — | — | 0 |
| 2017 | — | — | — | — | — | 0 |
| 2016 | — | — | — | — | — | 0 |
| 2015 | — | — | — | — | — | 0 |
| 2014 | — | — | — | — | — | 0 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 26 Jun 2026 | Company’s own | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 13 May 2025 | Company’s own | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 14 Apr 2024 | Company’s own | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 20 Jun 2023 | Company’s own | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 29 Jun 2022 | Company’s own | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 16 Jun 2021 | Company’s own | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 24 Sep 2020 | Company’s own | e-Äriregister |
Board
- Külli ReinoBoard member · since 2 Oct 2013
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- Külli ReinoNatural person · 2 500 €
Beneficial owners
- Külli ReinoDirect ownership · since 29 Oct 2018
Founders and other persons
- Külli ReinoFounder · 2 500 € · 1 Oct 2013
Related companies
Activities (EMTAK)
- 8699Other human health activities n.e.c. Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 20065349 / 7 2 Jan 2024 |
Amendment entry | In force 2 Jan 2024 |
||
| Ä 20065349 / M1 29 Dec 2023 |
Ruling to eliminate deficiencies | 13 Jan 2024 | Deficiencies eliminated 2 Jan 2024 |
|
| Ä 20065349 / 6 2 Sep 2023 |
Amendment entry | In force 2 Sep 2023 |
||
| Ä 20065349 / 5 3 Aug 2023 |
Amendment entry | In force 3 Aug 2023 |
||
| Ä 20065349 / 4 19 Jan 2018 |
Amendment entry | In force 19 Jan 2018 |
||
| Ä 20065349 / 3 19 Dec 2017 |
Amendment entry | In force 19 Dec 2017 |
||
| Ä 20065349 / 2 6 Dec 2017 |
Amendment entry | In force 6 Dec 2017 |
||
| Ä 20065349 2 Oct 2013 |
First entry | In force 2 Oct 2013 |
Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data